Related Experiment Video
Updated: Jun 20, 2026

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
Published on: November 14, 2016
[Neuropsychology of primary progressive multiple sclerosis]
R A Paes1, R M P Alvarenga, C C F Vasconcelos
1Universidad Federal del Estado de Río de Janeiro (UniRio), Hospital Universitario Gaffrée e Guinle, Río de Janeiro, Brasil. renataa.paes@globo.com
Introduction:
Cognitive impairment is a symptom of multiple sclerosis (MS); however, in the primary progressive form of the disease (PPMS), data on the prevalence and type of cognitive impairment are controversial.
Aim:
To evaluate the frequency of cognitive impairment, according to the diagnostic criteria defined by Thompson, in Brazilian patients with PPMS attending a referral center for the treatment of MS in Rio de Janeiro, Brazil.
Subjects And Methods:
A battery of neuropsychological tests was used to evaluate the following cognitive functions: screening for dementia, attention/concentration, speed of information processing, verbal fluency, memory and abstract/conceptual thought. The Beck scale was used to evaluate mood disorders. Twenty-six patients with PPMS and 26 controls paired for gender, age and education level were evaluated. Statistical analysis was based on the study performed by Rao.
Results:
The frequency of cognitive impairment in the PPMS patients in the present study was 50%. The cognitive functions most affected were: recent memory (60%), verbal fluency (40%) and speed of information processing (40%). Depression was more common in the PPMS patients compared to the control group; however, no association was found between cognitive impairment and depression.
Conclusion:
These results confirm the presence of cognitive impairment in PPMS and emphasize the need for further studies with larger sample sizes.
Related Concept Videos
Multiple Sclerosis l: Introduction
Parkinson's Disease: Overview
Parkinson Disease ll: Pathophysiology
Alzheimer Disease ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

